Gilead, Boehring Ingelheim and Takeda have contributed to a $59.6m round for Hookipa, a developer of immunotherapies for infectious diseases and cancer.
Author: Sam McCaffrey
Ferreira flees WME for FirstMark
Beth Ferreira has rejoined VC firm FirstMark Capital as managing director, bringing an end to her time at corporate venturing unit WME Ventures.
Vion invites corporates for $20m series B
Samsung and ABB have contributed to a $20m round for smart vision product developer Vion Technology, which will use the cash for hiring and product development.
Asilomar Bio harvests series B cash
The crop additive developer has secured $12.3m for product development and commercialisation from a consortium led by Syngenta.
SIG connects with Graduway
Alumni networking platform provider Graduway has received a $12.7m investment from Susquehanna Growth Equity, a subsidiary of Susquehanna International Group.
Modsy enters funding mode to raise $23m
US-based 3D imaging home design service provider Modsy has raised $23m in a series B round led by Advance Venture Partners (AVP), the venture and growth capital affiliate of media company Advance Publications. The round included GV and BBG Ventures, respective vehicles for internet technology provider Alphabet and online media group Oath, as well as Comcast… Continue reading Modsy enters funding mode to raise $23m
6 Dimensions seeks $26m for affiliates fund
The firm, formed by the merger of WuXi Healthcare Ventures and Frontline Bioventures, is raising a $26m affiliates fund according to a securities filing.
Earny claims $9m
Comcast Ventures has contributed to a $9m round for payment claims services provider Earny that was led by Mayfield Fund.
Boxful boxes up series B cash
Shimao Property, Nan Fung and Shui On Land have contributed to a $17.9m series B round for property storage provider Boxful.
SoftBank considers $300m delivery for DoorDash
SoftBank is in talks with food delivery service DoorDash regarding a $300m investment from its Vision Fund.
Etong Healthcare books series B funding
Dalian Yifang Group has contributed to a $30.2m series B round for Etong, which will use the funding to expand its customised checkup services.
AmorChem generates second Merck-backed fund
VC fund manager AmorChem has launched AmorChem II, a $44.2m seed-stage life sciences fund backed by Merck & Co.
Corporates pay for a piece of Obsidian
Alphabet, Takeda, ShangPharma and Amgen were among the investors in gene and cell therapy startup Obsidian Therapeutics’ $49.5m series A round.
NGData customises $19m series C
ING-backed customer data software developer NGData will use the series C proceeds to accelerate international growth.